Measles virus remains a significant source of vaccine preventable disease in sub-Saharan Africa. The recent proliferation of rapid diagnostic testing presents a new tool in the fight to eliminate measles. Point-of-care rapid diagnostics present an opportunity to scale up, and speed up, diagnostic confirmation of suspected measles cases in settings with limited laboratory capacity. We are working on a new project with Gavi, the Alliance for Vaccines to develop strategies for deployment of rapid diagnostic testing for measles virus to support areas with limited diagnostic infrastructure. 

Speaker: Matthew Ferrari  |  Biology